Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,445 | -8,277 | -5,463 | -2,744 | -9,689 |
| Depreciation Amortization | 208 | 147 | 87 | 35 | 79 |
| Accounts payable and accrued liabilities | -431 | -167 | -198 | -144 | 198 |
| Other Working Capital | 104 | -238 | -441 | -534 | -443 |
| Other Operating Activity | 1,030 | 621 | 503 | 274 | 449 |
| Operating Cash Flow | $-10,534 | $-7,914 | $-5,512 | $-3,113 | $-9,406 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -9 | -7 | -2 | -19 |
| Investing Cash Flow | $-11 | $-9 | $-7 | $-2 | $-19 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 37,000 | 37,000 | 34,389 | N/A | 9,038 |
| Other Financing Activity | -3,007 | -2,949 | -138 | -55 | -1,015 |
| Financing Cash Flow | $33,993 | $34,051 | $34,251 | $-55 | $8,023 |
| Beginning Cash Position | 15,354 | 15,354 | 15,354 | 15,354 | 16,756 |
| End Cash Position | 38,802 | 41,482 | 44,086 | 12,184 | 15,354 |
| Net Cash Flow | $23,448 | $26,128 | $28,732 | $-3,170 | $-1,402 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,534 | -7,914 | -5,512 | -3,113 | -9,406 |
| Capital Expenditure | -11 | -9 | -7 | -2 | -19 |
| Free Cash Flow | -10,545 | -7,923 | -5,519 | -3,115 | -9,425 |